Searchable abstracts of presentations at key conferences in endocrinology

ea0081ep484 | Diabetes, Obesity, Metabolism and Nutrition | ECE2022

Quality of life, anxiety-depressive disorders and their assessment in patients with metabolic syndrome

Moskalenko Olga , Kasparov Eduard

This article discusses the assessment of quality of life, psychological state and anxiety-depressive disorders in patients with metabolic syndrome. It is known that the prevalence of metabolic syndrome in different countries is about 30% and varies from included criteria. The problem of the quality of life of obese and overweight patients is relevant and socially significant. Research Methods The authors present the results of a study of 70 patients with MS and 36 apparently h...

ea0063p166 | Diabetes, Obesity and Metabolism 1 | ECE2019

Assessment of the functional activity of neutrophilic granulocytes in patients with metabolic syndrome

Smirnova Olga , Kasparov Eduard , Moskalenko Olga

Introduction: Metabolic syndrome (MS) is a common disease with up to 25% of the total adult population and more than 45% of those over 60 years of age. When MS develops a complex of metabolic disorders that contribute to the development of vascular atherosclerotic diseases, such as abdominal obesity, hypertension, insulin resistance, dyslipidemia. Exchange disorders in MS are associated with the development of inflammation in organs and vessels, while the role of neutrophils i...

ea0063ep31 | Diabetes, Obesity and Metabolism | ECE2019

Interrelation between obesity, metabolic syndrome and molecular-genetic mechanisms of their formation

Smirnova Olga , Kasparov Eduard , Moskalenko Olga

Introduction: Metabolic syndrome (MS) is a disease that develops in obesity in adult patients with the development of numerous metabolic and vascular disorders. In patients with MS, the risk of developing cardiovascular diseases is increased compared to the general population by 1.78 times as a whole and 2.25 times in women. Currently, the number of overweight children and the development of metabolic complications such as fatty liver, hypertension, and type 2 diabetes are inc...

ea0070aep469 | Diabetes, Obesity, Metabolism and Nutrition | ECE2020

Role of biochemical indices in the pathogenesis of metabolic syndrome

Smirnova Olga , Kasparov Eduard , Moskalenko Olga

The defeat of the metabolic syndrome (MS) of young people with the development of severe vascular and diabetic complications determines the relevance of its study for the purpose of early diagnosis. Changes in blood at the preclinical stage of MS are reversible, while the main pathogenetic factors of MS are insulin resistance and dyslipidemia. The aim of the study was to assess the role of biochemical parameters in the pathogenesis of MS.Materials and me...

ea0073ep83 | Diabetes, Obesity, Metabolism and Nutrition | ECE2021

Assessment of biochemical indicators in laboratory diagnostics of metabolic syndrome

Moskalenko Olga , Smirnova Olga , Kasparov Eduard

Metabolic syndrome (MS) is one of the most pressing problems of modern medicine. MS is a symptom complex of impaired carbohydrate metabolism, abdominal obesity, dyslipidemia, hypertension with an increased risk of developing cardiovascular diseases and type 2 diabetes mellitus. The main reasons for the increase in the incidence of MS are a decrease in physical activity and a high-calorie diet. The prevalence of MS in different countries is 25–30% and varies depending on t...